Prot# 2055-003: A Phase 2, Multi-Center, Randomized, Open-Label Study of Two Dose Levels of IMOxine? (HYB2055 for Injection) in Patients with Metastatic or Locally Recurrent Clear Cell Renal Carcinoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/23/05 → 9/1/11

Funding

  • Hybridon, Inc. (2055-003)